Joseph Wiley is the founder of Chiasma. Chiasma has raised $161M in total funding. Backed by Abingworth, ARCH Venture Partners, MPM Capital.
Joseph Wiley is the CEO of Chiasma, a biopharmaceutical company that focuses on oral therapies for rare and chronic diseases. Chiasma was acquired by Amryt Pharma in May 2021 for approximately $339 million, and Wiley continued as CEO after the acquisition.
Full founder directory · Investor directory · Company funding database · Fundraising library